Get started
NLS Pharmaceutics Ltd.NLS Pharmaceutics Ltd.NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

NLSP chart


Full chart

NLSP upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.20 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−12.17 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪1.57 M‬
Beta (1Y)
0.02

Employees


Employees (FY)
4
Change (1Y)
+2 +100.00%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−3.04 M‬ USD

About NLS Pharmaceutics Ltd.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Alexander C. Zwyer
Website
nlspharma.com
Headquarters
Zurich
Founded
2015
ISIN
CH1384053976
FIGI
BBG00S2L23F4
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by Ronald Hafner, Eric Konofal, and Alexander Zwyer on June 10, 2015 and is headquartered in Zurich, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NLSP news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as NLSP.

Frequently Asked Questions


The current price of NLSP is 1.67 USD — it has decreased by −2.94% in the past 24 hours. Watch NLS Pharmaceutics Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NLS Pharmaceutics Ltd. stocks are traded under the ticker NLSP.
NLSP stock has risen by 12.24% compared to the previous week, the month change is a 13.79% rise, over the last year NLS Pharmaceutics Ltd. has showed a −71.01% decrease.
NLSP reached its all-time high on Mar 12, 2021 with the price of 294.00 USD, and its all-time low was 1.30 USD and was reached on Mar 28, 2025. View more price dynamics on NLSP chart.
See other stocks reaching their highest and lowest prices.
NLSP stock is 5.48% volatile and has beta coefficient of 0.02. Track NLS Pharmaceutics Ltd. stock price on the chart and check out the list of the most volatile stocks — is NLS Pharmaceutics Ltd. there?
Today NLS Pharmaceutics Ltd. has the market capitalization of ‪4.08 M‬, it has increased by 3.74% over the last week.
Yes, you can track NLS Pharmaceutics Ltd. financials in yearly and quarterly reports right on TradingView.
NLS Pharmaceutics Ltd. is going to release the next earnings report on Sep 3, 2025. Keep track of upcoming events with our Earnings Calendar.
No, NLSP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 9, 2025, the company has 4 employees. See our rating of the largest employees — is NLS Pharmaceutics Ltd. on this list?
Like other stocks, NLSP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NLS Pharmaceutics Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NLS Pharmaceutics Ltd. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NLS Pharmaceutics Ltd. stock shows the sell signal. See more of NLS Pharmaceutics Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.